US Healthcare BPO Market Share and Industry Trends (2019-2029) Featuring UnitedHealth Group, Cognizant, Accenture, Genpact, IBM, and More
April 02, 2024 12:19 ET
|
Research and Markets
Dublin, April 02, 2024 (GLOBE NEWSWIRE) -- The "US Healthcare BPO - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019-2029" report has been added to ...
GRI Bio Commences Patient Enrollment in Phase 2a Biomarker Study Evaluating Lead Program GRI-0621 for the Treatment of Idiopathic Pulmonary Fibrosis (“IPF”)
December 05, 2023 09:05 ET
|
GRI Bio, Inc.
Clinical development plan potentially leveraging 505(b)(2) regulatory pathway Currently available treatments for IPF are limited to only two approved drugs that come with significant...
Global Clinical Trial Patient Recruitment Services Market Expected to Reach $1.56 Billion by 2030, Driven by Growing Pharma Sector
October 18, 2023 09:58 ET
|
Research and Markets
Dublin, Oct. 18, 2023 (GLOBE NEWSWIRE) -- The "Clinical Trial Patient Recruitment Services Market Size, Share & Trends Analysis Report By Service Type, By Phase, By Therapeutic Area, By Age...
Global Healthcare BPO Market Forecast Report 2023-2030: Driving Forces - Rising Demands for Pharmacovigilance Propel Market
September 07, 2023 06:38 ET
|
Research and Markets
Dublin, Sept. 07, 2023 (GLOBE NEWSWIRE) -- The "Global Healthcare BPO Market by Payer Service, Pharmaceutical Service, Provider Service - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and...
Global SYK Inhibitors Market & Clinical Trials Outlook Report 2023-2028: Potential $300 Million Opportunity, 1 Marketed Drug, Current & Forecast Sales, Competitive Landscape
May 24, 2023 06:08 ET
|
Research and Markets
Dublin, May 24, 2023 (GLOBE NEWSWIRE) -- The "Global SYK Inhibitors Market & Clinical Trials Outlook 2028" report has been added to ResearchAndMarkets.com's offering. This report contains a...
QSAM Biosciences Expands its Study of CycloSam® in the Treatment of Bone Cancer; Opens Patient Enrollment at Key Chicago Center, Insight Hospital and Medical Center
May 23, 2023 08:00 ET
|
QSAM Biosciences Inc.
Austin, TX, May 23, 2023 (GLOBE NEWSWIRE) -- QSAM Biosciences Inc. (OTCQB: QSAM), a company developing next generation therapeutic radiopharmaceuticals, including Samarium-153-DOTMP (CycloSam®), for...
Outlook on the SYK Inhibitors Global Market to 2028 - Players Include Calithera Biosciences, CrystalGenomics, CSPC Ouyi Pharmaceutical, Genosco and Hanmi Pharmaceutical
February 24, 2023 05:18 ET
|
Research and Markets
Dublin, Feb. 24, 2023 (GLOBE NEWSWIRE) -- The "Global SYK Inhibitors Market & Clinical Trials Outlook 2028" report has been added to ResearchAndMarkets.com's offering. This report contains a...
Patient Recruitment Services and Patient Retention Services Global Market Report 2022: Increasing Clinical Development Activity in Emerging Economies Drives Growth
December 08, 2022 08:43 ET
|
Research and Markets
Dublin, Dec. 08, 2022 (GLOBE NEWSWIRE) -- The "Patient Recruitment Services and Patient Retention Services Market by Patient Recruitment Step, Trial Phase Therapeutic Area and Key Geographies,...
$277+ Billion Worldwide Healthcare BPO Industry to 2031: Rapid Increase of Clinical Process Outsourcing is Significantly Driving Growth
October 21, 2022 04:28 ET
|
Research and Markets
Dublin, Oct. 21, 2022 (GLOBE NEWSWIRE) -- The "Healthcare BPO Global Market Report 2022" report has been added to ResearchAndMarkets.com's offering. This report provides strategists, marketers...
Phathom Pharmaceuticals to Present Latest Data on Vonoprazan at American College of Gastroenterology (ACG) 2022 Annual Scientific Meeting
October 18, 2022 08:00 ET
|
Phathom Pharmaceuticals
FLORHAM PARK, N.J., Oct. 18, 2022 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on developing and commercializing novel treatments for...